FAT1 and PTPN14 Regulate the Malignant Progression and Chemotherapy Resistance of Esophageal Cancer through the Hippo Signaling Pathway
Analytical Cellular Pathology2021Vol. 2021, pp. 1–9
Citations Over TimeTop 22% of 2021 papers
Abstract
The results suggested that PTPN14 and FAT1 could regulate malignant progression and chemotherapy resistance of esophageal cancer based on the Hippo signaling pathway.
Related Papers
- → Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis(2016)303 cited
- → Identification of a new class of activators of the Hippo pathway with antitumor activity in vitro and in vivo(2024)3 cited
- → The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version(2010)1,133 cited
- → Abstract IA04: Regulation of the Hippo pathway in cancer(2020)
- → P04.20 The role of YAP in Glioblastoma cell lines(2021)